Monthly Prescribing Reference

Systolic BP Target of Less Than 120 mm Hg Favored for Most Participants in BP Trial

Net benefits of treatment were compared across categories of age, SPRINT-derived frailty status, and polypharmacy. HealthDay News — Most older adults in the Systolic Blood Pressure Intervention Trial ...
Monthly Prescribing Reference

Intensive Systolic BP Target Cost-Effective for Patients at High Cardiovascular Risk

Intensive target less than 120 mm Hg cost-effective even in scenarios with high measurement error. HealthDay News — For patients 50 years or older at high ...
Nasdaq

ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System

The investigational device exemption (IDE) allows initiation of a global pivotal study designed to assess the safety and efficacy of the ARCIM System®, an implantable neurostimulation technology ...
Renal & Urology News

Systolic BP Target <120 mm Hg Favored for Most Participants in BP Intervention Trial

Almost all older adults in SPRINT trial have predicted net benefit favoring systolic BP target 120 mm Hg versus 140 mm Hg. (HealthDay News) — Most older adults in the Systolic Blood Pressure ...